Role of the APOE polymorphism in carotid and lower limb revascularization: A prospective study from Southern Italy. (scientific article)

Apolipoprotein E polymorphisms predict low density lipoprotein cholesterol levels and carotid artery wall thickness but not incident coronary heart disease in 12,491 ARIC study participants

Q83946316

Parental history and the risk of subsequent vascular events in patients with clinically manifest vascular disease: the effects of sex of the parent and vascular disease location

Q87481987

Apolipoprotein E and atherosclerosis: beyond lipid effect

Q45244818

The missing ApoE allele

Q48082099

Incremental value of a genetic risk score for the prediction of new vascular events in patients with clinically manifest vascular disease

Q48325746

The role of apolipoprotein E polymorphism in improving dyslipidemia in obese adolescents following physical exercise and National Cholesterol Education Program Step II intervention.

Q50989653

Interaction of apolipoprotein E genotype with smoking and physical inactivity on coronary heart disease risk in men and women.

Q51390875

Carotid atherosclerosis, vascular risk profile and mortality in a population-based sample of functionally healthy elderly subjects: the Berlin ageing study.

Q51555251

Simple and effective determination of apolipoprotein E genotypes by positive/negative polymerase chain reaction products.

Q54585946

Inflammation in atherosclerosis

Q57295305

Association ofAPOEgenotype with carotid atherosclerosis in men and women

Q57337129

TOMM40, APOE, and APOC1 in Primary Progressive Aphasia and Frontotemporal Dementia

Q58005724

Genetics of atherosclerosis

Q59447234

The presence of apolipoprotein ε4 and ε2 alleles augments the risk of coronary artery disease in type 2 diabetic patients

Q62071609

Apolipoprotein E polymorphisms and mortality in Italian type 2 diabetic patients

Q73185210

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

Q27860959

A simple salting out procedure for extracting DNA from human nucleated cells

Q27861086

Patient-level costs of major cardiovascular conditions: a review of the international literature

Q28076912

APOE ε4 is associated with higher vitamin D levels in targeted replacement mice and humans

Q28240143

Association of apolipoprotein E genotypes with lipid levels and coronary risk

Q28249437

Apolipoprotein E isoforms and lipoprotein metabolism

Q28249988

Association of Cardiometabolic Multimorbidity With Mortality

Q28606934

Calcified carotid atherosclerotic plaque is associated less with ischemic symptoms than is noncalcified plaque on MDCT

Q30434511

APOE polymorphism is associated with lipid profile, but not with arterial stiffness in the general population

Q34351034

Heart Disease and Stroke Statistics-2016 Update: A Report From the American Heart Association

Q34505315

E2 allele of the apolipoprotein E gene polymorphism is predictive for obesity status in Roma minority population of Croatia

Q34515304

Diversity of apolipoprotein E genetic polymorphism significance on cardiovascular risk is determined by the presence of metabolic syndrome among hypertensive patients

Q34643186

Meta-analysis of apolipoprotein E gene polymorphism and susceptibility of myocardial infarction

Q35222771

Apolipoprotein ε4 polymorphism does not modify the association between body mass index and high-density lipoprotein cholesterol: a cross-sectional cohort study.

Q35277110

Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease

Q36023835

Serum uric acid as a prognostic marker in the setting of advanced vascular disease: a prospective study in the elderly.

Q36162192

Apolipoprotein E polymorphism modulation of asymmetric dimethylarginine in hypertensive patients is determined by renal function

Q36481807

Apolipoprotein E gene polymorphism and risk of type 2 diabetes and cardiovascular disease

Q36493730

Apolipoprotein E epsilon 2 allele and low serum cholesterol as risk factors for gastric cancer in a Chinese Han population

Q36511996

Identification of atherosclerosis-modifying genes: pathogenic insights and therapeutic potential

Q36642686

The relationship between apolipoprotein E gene ε2/ε3/ε4 polymorphism and breast cancer risk: a systematic review and meta-analysis

Q36682416

Role of arterial stiffness in cardiovascular disease

Q37082512

Incremental increases in economic burden parallels cardiometabolic risk factors in the US.

Q37158376

25-hydroxyvitamin D levels inversely associate with risk for developing coronary artery calcification

Q37297677

Gene polymorphisms in APOE, NOS3, and LIPC genes may be risk factors for cardiac adverse events after primary CABG.

Q37329078

The genetics of the human APOE polymorphism

Q37940538

Association between apolipoprotein E genotype and cancer susceptibility: a meta-analysis.

Q38202567

Epidemiology of classical risk factors in stroke patients in the Middle East

Q38515153

Dysfunctional HDL and atherosclerotic cardiovascular disease

Q38577283

Obesity, Diabetes, and Other Cardiovascular Risk Factors in Native Populations of South America

Q38701340

Using the Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) Statement to assess reporting of observational trials in hand surgery

Q38801788

Association of apolipoprotein E gene polymorphism with ischemic stroke involving large-vessel disease and its relation to serum lipid levels

Q39422035

The relation between apolipoprotein E (APOE) genotype and peripheral artery disease in patients at high risk for cardiovascular disease

Q40957173

Heterogeneous impact of classic atherosclerotic risk factors on different arterial territories: the EPIC-Norfolk prospective population study

Q41038575

APOE and TGF-beta1 genes are associated with obesity phenotypes

Q43074395

Apolipoprotein E isoforms, serum cholesterol, and cancer. 1986.

Q44838029

Trends in the epidemiology of cardiovascular disease in the UK

Q26739897

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders

Q26747482

Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990-2013: a systematic analysis for the Global Burden of Disease Study 2013.

Q26782024

P275

Creative Commons Attribution 4.0 International

copyrighted

issue

language of work or name

English